This trial is terminated!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Cancer or Hepatic Injury
and you are
between 18 and 80
years old
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

The purposes of this study are to make Omegaven® available to cancer patients with liver disease and to determine if Omegaven® can improve or prevent further liver disease. The study will also look at the effects Omegaven® has on immune function.

Provided treatments

  • Drug: Omegaven

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01325584. The sponsor of the trial is Midwestern Regional Medical Center and it is looking for 12 volunteers for the current phase.
Official trial title:
Compassionate Use of Omegaven® in the Treatment of Parenteral Nutrition Induced Hepatic Injury